C. Di

发表

Glioblastoma Multiforme Oncogenomics and Signaling Pathways

Darell D. Bigner, Jinrong Fu, Hai Yan, 2009, Clinical medicine. Oncology.

The future role of personalized medicine in the treatment of glioblastoma multiforme

A. Mattox, C. Di, Jing Li, 2010, Pharmacogenomics and personalized medicine.

Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention.

A. Friedman, R. Babu, C. Di, 2012, Neurosurgical focus.

Transcriptional Activation of the SALL1 by the Human SIX1 Homeodomain during Kidney Development*

Yupo Ma, W. Cui, K. Kawakami, 2006, Journal of Biological Chemistry.

AJAP1 is Dysregulated at an Early Stage of Gliomagenesis and Suppresses Invasion Through Cytoskeleton Reorganization

T. Jiang, C. Kang, Junxia Zhang, 2014, CNS neuroscience & therapeutics.

Medulloblastoma: Role of OTX2 Transcription Factors

A. Mattox, C. Di, Jing Li, 2012 .

Glioblastoma multiforme: a review of where we have been and where we are going

D. Bigner, A. Mattox, Darell D Bigner, 2009, Expert opinion on investigational drugs.

Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.

R. Auten, Songtao Li, Zhen Yan, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4)

W. Han, C. Di, D. Ma, 2005, Life Sciences.

SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.

J. Ritz, Yupo Ma, W. Cui, 2006, Blood.

[Preparation and identification of monoclonal antibodies against human apoptosis-related protein TFAR19].

Y. Chen, C. Di, D. Ma, 2000, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal.

H. Liu, Y. Wang, Hongtao Liu, 1999, Biochemical and biophysical research communications.

Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis?

Y. Chen, W. Han, C. Di, 2001, FEBS letters.

OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.

C. Di, Jing Li, D. C. Adamson, 2015, International journal of oncology.

Glioblastoma multiforme: a review of therapeutic targets.

Hai Yan, D. Bigner, O. Kanu, 2009, Expert opinion on therapeutic targets.

Glioblastoma multiforme: a review of therapeutic targets

Hai Yan, D. Bigner, O. Kanu, 2009, Expert opinion on therapeutic targets.

Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas

R. McLendon, V. Velculescu, T. Parrett, 2004, Cancer Research.

Identification of microbial DNA in human cancer

Tian-Li Wang, Bert Vogelstein, C. Schaefer, 2009, BMC Medical Genomics.

Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

R. McLendon, Hai Yan, D. Bigner, 2009, Cancer research.

AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival

D. Bigner, C. Di, B. Fee, 2017, International journal of oncology.

The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.

C. Kang, C. Di, B. Fee, 2014, International journal of oncology.

Deletion or Epigenetic Silencing of AJAP1 on 1p36 in Glioblastoma

Jinrong Fu, R. McLendon, P. Truszkowski, 2012, Molecular Cancer Research.

OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.

R. McLendon, Hai Yan, D. Bigner, 2010, Cancer research.

HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.

R. McLendon, S. Keir, Hai Yan, 2010, Neuro-oncology.

Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity.

L. Wang, Ya-xin Lou, Y. Chen, 2001, The Biochemical journal.

Emerging therapeutic targets and agents for glioblastoma migrating cells.

A. Mattox, C. Di, Cory Adamson, 2010, Anti-cancer agents in medicinal chemistry.

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.

R. McLendon, V. Velculescu, T. Parrett, 2005, Cancer research.

Effects of novel human chemokine-like factor 1 (CKLF1) on bone marrow hematopoietic stem cell/progenitor cell in vitro.

X. Ke, C. Di, H. Jing, 2002, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Overexpression of chemokine-like factor 2 promotes the proliferation and survival of C2C12 skeletal muscle cells.

Ya-xin Lou, W. Han, C. Di, 2002, Biochimica et biophysica acta.

[Stimulatory effect of chemokine-like factor 1 (CKLF1) on the growth of bone marrow cells].

W. Han, C. Di, Q. Song, 2001, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival

D. Bigner, Chunsheng Kang, C. Kang, 2017, International journal of oncology.

Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

R. McLendon, Hai Yan, D. Bigner, 2009, Cancer research.

Deletion or Epigenetic Silencing of AJAP1 on 1p36 in Glioblastoma

R. McLendon, P. Truszkowski, D. Bigner, 2012, Molecular Cancer Research.